ROS-responsive nanoparticle-mediated delivery of CYP2J2 gene for therapeutic angiogenesis in severe hindlimb ischemia.
ROS-responsive nanoparticle-mediated delivery of CYP2J2 gene for therapeutic angiogenesis in severe hindlimb ischemia.
复制标题
ROS响应纳米颗粒介导的CYP2J2基因递送用于治疗严重后肢缺血的血管生成
DOI:
10.1016/j.mtbio.2021.100192
复制
发表时间:
2022-01
期刊:
影响因子:
--
通讯作者:
Li Y
中科院分区:
文献类型:
--
作者:
Gui L;Chen Y;Diao Y;Chen Z;Duan J;Liang X;Li H;Liu K;Miao Y;Gao Q;Li Z;Yang J;Li Y
With critical limb ischemia (CLI) being a multi-factorial disease, it is becoming evident that gene therapy with a multiple bio-functional growth factor could achieve better therapeutic outcomes. Cytochrome P450 epoxygenase-2J2 (CYP2J2) and its catalytic products epoxyeicosatrienoic acids (EETs) exhibit pleiotropic biological activities, including pro-angiogenic, anti-inflammatory and cardiovascular protective effects, which are considerably beneficial for reversing ischemia and restoring local blood flow in CLI. Here, we designed a nanoparticle-based pcDNA3.1-CYP2J2 plasmid DNA (pDNA) delivery system (nanoparticle/pDNA complex) composed of a novel three-arm star block copolymer (3S-PLGA-po-PEG), which was achieved by conjugating three-armed PLGA to PEG via the peroxalate ester bond. Considering the multiple bio-functions of CYP2J2-EETs and the sensitivity of the peroxalate ester bond to H2O2, this nanoparticle-based gene delivery system is expected to exhibit excellent pro-angiogenic effects while improving the high oxidative stress and inflammatory micro-environment in ischemic hindlimb. Our study reports the first application of CYP2J2 in the field of therapeutic angiogenesis for CLI treatment and our findings demonstrated good biocompatibility, stability and sustained release properties of the CYP2J2 nano-delivery system. In addition, this nanoparticle-based gene delivery system showed high transfection efficiency and efficient VEGF expression in vitro and in vivo. Intramuscular injection of nanoparticle/pDNA complexes into mice with hindlimb ischemia resulted in significant rapid blood flow recovery and improved muscle repair compared to mice treated with naked pDNA. In summary, 3S-PLGA-po-PEG/CYP2J2-pDNA complexes have tremendous potential and provide a practical strategy for the treatment of limb ischemia. Moreover, 3S-PLGA-po-PEG nanoparticles might be useful as a potential non-viral carrier for other gene delivery applications. Cytochrome P450 epoxygenase-2J2 (CYP2J2) was first applied in the field of therapeutic angiogenesis for critical limb ischemia treatment. The ROS-responsive three-arm star block copolymer (3S-PLGA-po-PEG) was synthesized with peroxalate ester as H2O2-responsive linkages through the esterification reaction of oxalyl chloride and hydroxyl group. The CYP2J2 nano-delivery system achieved high transfection efficiency and significant therapeutic angiogenesis effect.
登录
查看更多内容
影响因子:
4.4
作者:
Capozzi, Megan E.;McCollum, Gary W.;Penn, John S.
通讯作者:
Penn, John S.
影响因子:
6.5
作者:
Cai, Zhejun;Zhao, Gang;Wang, Dao Wen
通讯作者:
Wang, Dao Wen
影响因子:
9.7
作者:
Bao, Hanmei;Lv, Feng;Liu, Tianjun
通讯作者:
Liu, Tianjun
影响因子:
4.3
作者:
Guillot, Max;Charles, Anne-Laure;Geny, Bernard
通讯作者:
Geny, Bernard
影响因子:
14
作者:
Kang, Sun-Woong;Lim, Hee-Won;Kim, Byung-Soo
通讯作者:
Kim, Byung-Soo